Ignite Creation Date:
2024-07-17 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463457
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-11
Brief Title:
Comeback From Long coursE Androgen Deprivation Therapy ADT With RElugolix and Darolutamide CLEARED
Sponsor:
Atish Choudhury MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
24-217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Atish Choudhury MD
Lead Sponsor Class:
OTHER
Responsible Party:
Atish Choudhury MD
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
| Pfizer | INDUSTRY |
| Sumitomo Pharma America Inc | INDUSTRY |
| National Comprehensive Cancer Network | NETWORK |